Header Logo

Michael Silverberg

Concepts (630)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
156
2024
694
27.140
Why?
Anti-HIV Agents
42
2024
155
6.940
Why?
Neoplasms
22
2024
438
4.860
Why?
Humans
235
2024
17611
4.380
Why?
Adult
155
2024
7598
4.140
Why?
Male
175
2024
10008
4.090
Why?
CD4 Lymphocyte Count
59
2024
178
3.990
Why?
Antiretroviral Therapy, Highly Active
27
2020
93
3.880
Why?
Female
176
2024
12608
3.800
Why?
Middle Aged
134
2024
7911
3.800
Why?
Acquired Immunodeficiency Syndrome
15
2023
63
3.700
Why?
Cohort Studies
83
2024
2570
3.390
Why?
Viral Load
32
2024
135
3.370
Why?
Anti-Retroviral Agents
18
2023
80
3.070
Why?
Uterine Cervical Neoplasms
11
2022
119
2.740
Why?
Risk Factors
55
2024
3325
2.250
Why?
California
43
2024
2284
2.130
Why?
Mouth Neoplasms
4
2020
9
2.080
Why?
HIV-1
18
2017
70
2.080
Why?
Hepatitis C
10
2023
65
2.070
Why?
Transgender Persons
11
2024
38
1.970
Why?
Pre-Exposure Prophylaxis
8
2024
19
1.900
Why?
Aged
50
2024
6095
1.880
Why?
Critical Illness
4
2015
50
1.870
Why?
Alcohol Drinking
7
2021
368
1.860
Why?
Substance-Related Disorders
11
2024
434
1.750
Why?
United States
51
2024
3956
1.630
Why?
Leukoplakia, Oral
3
2020
3
1.590
Why?
Continuity of Patient Care
7
2022
105
1.580
Why?
Incidence
33
2021
1255
1.580
Why?
Retrospective Studies
33
2024
2447
1.570
Why?
Life Expectancy
4
2020
33
1.520
Why?
Coinfection
7
2023
30
1.500
Why?
Dementia
2
2024
106
1.480
Why?
Delivery of Health Care, Integrated
12
2021
531
1.470
Why?
Papillomavirus Infections
8
2022
133
1.400
Why?
Papillomavirus Vaccines
3
2020
113
1.360
Why?
Critical Care
3
2014
71
1.340
Why?
Continental Population Groups
3
2019
302
1.320
Why?
Young Adult
41
2023
2427
1.320
Why?
Smoking
6
2021
483
1.260
Why?
Adenocarcinoma
4
2022
172
1.240
Why?
Drug Prescriptions
6
2023
151
1.240
Why?
Medication Adherence
6
2020
244
1.240
Why?
Reverse Transcriptase Inhibitors
7
2024
24
1.240
Why?
Carcinoma, Squamous Cell
5
2017
55
1.220
Why?
Healthcare Disparities
5
2018
201
1.210
Why?
Socioeconomic Factors
8
2024
630
1.200
Why?
Myocardial Infarction
5
2024
238
1.170
Why?
Sarcoma, Kaposi
4
2021
12
1.110
Why?
Ethnic Groups
5
2021
485
1.100
Why?
Laryngoscopy
3
2015
3
1.100
Why?
Pain
8
2024
79
1.100
Why?
Adolescent
41
2024
3651
1.050
Why?
RNA, Viral
18
2024
64
1.040
Why?
Skin Neoplasms
3
2017
57
1.020
Why?
Video-Assisted Surgery
2
2015
2
1.010
Why?
Intubation, Intratracheal
2
2015
6
1.000
Why?
HIV
10
2023
26
1.000
Why?
Carcinoma, Basal Cell
2
2017
24
0.990
Why?
Insurance, Health
5
2020
181
0.990
Why?
Proportional Hazards Models
21
2024
709
0.990
Why?
Papillomaviridae
6
2022
52
0.980
Why?
Hypertension
4
2024
500
0.970
Why?
Internal Medicine
2
2014
20
0.970
Why?
Video Recording
2
2014
12
0.960
Why?
Education, Medical, Graduate
2
2014
18
0.960
Why?
Bacteremia
1
2024
12
0.950
Why?
Antiviral Agents
4
2022
94
0.950
Why?
North America
20
2024
42
0.940
Why?
Lymphoma, AIDS-Related
4
2012
18
0.940
Why?
Primary Health Care
6
2024
766
0.930
Why?
Streptococcal Infections
1
2024
22
0.930
Why?
Suicidal Ideation
3
2024
100
0.930
Why?
Analgesics, Opioid
8
2024
243
0.920
Why?
Prevalence
20
2024
884
0.910
Why?
Mass Screening
8
2022
661
0.900
Why?
Anus Neoplasms
5
2020
26
0.890
Why?
Program Evaluation
2
2014
223
0.890
Why?
Hallucinogens
1
2024
23
0.880
Why?
Mental Health
7
2023
165
0.870
Why?
HIV Seropositivity
11
2017
31
0.870
Why?
Cervical Intraepithelial Neoplasia
3
2019
16
0.870
Why?
Risk Assessment
13
2024
1097
0.860
Why?
Early Detection of Cancer
8
2022
501
0.860
Why?
Fractures, Bone
1
2023
91
0.850
Why?
Alcoholism
4
2021
347
0.850
Why?
Fasciitis, Necrotizing
1
2022
1
0.830
Why?
Anti-Bacterial Agents
1
2024
140
0.830
Why?
Abdominal Wall
1
2022
2
0.830
Why?
Opioid-Related Disorders
2
2024
167
0.820
Why?
African Continental Ancestry Group
4
2018
162
0.820
Why?
Health Services Accessibility
6
2020
289
0.810
Why?
Cardiovascular Diseases
5
2024
598
0.810
Why?
Cannabis
1
2024
78
0.810
Why?
Comorbidity
11
2024
594
0.760
Why?
Electronic Health Records
6
2024
681
0.760
Why?
Tobacco Smoking
1
2021
20
0.730
Why?
Alphapapillomavirus
1
2020
13
0.710
Why?
Canada
20
2023
66
0.710
Why?
Precancerous Conditions
1
2020
47
0.710
Why?
Unsafe Sex
1
2020
19
0.710
Why?
Prostatic Neoplasms
4
2017
262
0.680
Why?
Condylomata Acuminata
6
2009
23
0.680
Why?
Case-Control Studies
10
2020
1115
0.680
Why?
Treatment Outcome
19
2019
1259
0.660
Why?
Motivational Interviewing
1
2019
33
0.650
Why?
Sexual and Gender Minorities
3
2024
27
0.650
Why?
Text Messaging
1
2019
29
0.640
Why?
Follow-Up Studies
13
2020
1210
0.640
Why?
Lymphoma, Non-Hodgkin
4
2015
24
0.640
Why?
Risk
8
2021
516
0.630
Why?
HIV Protease Inhibitors
4
2024
16
0.630
Why?
Smoking Cessation
1
2020
193
0.620
Why?
Colorectal Neoplasms
3
2020
613
0.620
Why?
Patient Compliance
8
2017
298
0.620
Why?
Medical Record Linkage
2
2015
38
0.610
Why?
Uterine Cervical Dysplasia
1
2018
8
0.600
Why?
Quality of Health Care
1
2020
326
0.600
Why?
Mental Disorders
4
2023
280
0.600
Why?
AIDS-Related Opportunistic Infections
5
2016
17
0.600
Why?
Renal Insufficiency, Chronic
4
2024
179
0.600
Why?
Prostate-Specific Antigen
2
2016
75
0.600
Why?
Lung Neoplasms
3
2017
255
0.600
Why?
Neoplasms, Multiple Primary
1
2017
15
0.590
Why?
Anxiety
5
2023
150
0.580
Why?
End Stage Liver Disease
4
2022
9
0.580
Why?
Common Variable Immunodeficiency
1
2017
5
0.580
Why?
Hepacivirus
6
2023
51
0.570
Why?
Heart Failure
1
2022
396
0.570
Why?
Age Factors
12
2019
917
0.560
Why?
Aged, 80 and over
15
2021
1900
0.560
Why?
Cross-Sectional Studies
13
2024
1322
0.560
Why?
Pneumonia
1
2017
51
0.550
Why?
Syphilis
2
2022
17
0.550
Why?
Prospective Studies
15
2022
1267
0.540
Why?
Pneumococcal Infections
1
2016
42
0.540
Why?
Dideoxynucleosides
1
2016
8
0.540
Why?
Hepatitis B
5
2023
42
0.530
Why?
Age Distribution
8
2021
246
0.530
Why?
Pneumococcal Vaccines
1
2016
64
0.530
Why?
Dyslipidemias
2
2024
62
0.520
Why?
Hepatitis B, Chronic
4
2022
27
0.520
Why?
Prognosis
10
2024
606
0.520
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2022
171
0.510
Why?
Oropharyngeal Neoplasms
1
2015
6
0.500
Why?
Biomarkers, Tumor
5
2017
142
0.500
Why?
Endoscopy
2
2014
10
0.500
Why?
Lymphoma, Large B-Cell, Diffuse
4
2017
14
0.500
Why?
Registries
8
2018
471
0.500
Why?
Ablation Techniques
1
2014
3
0.490
Why?
Tumor Suppressor Protein p53
1
2014
20
0.490
Why?
Papilloma
2
2004
2
0.460
Why?
Depression
4
2024
502
0.460
Why?
Liver Diseases
4
2012
23
0.460
Why?
Blood Vessels
1
2013
1
0.450
Why?
Ultrasonography, Interventional
1
2013
4
0.450
Why?
Homosexuality, Male
9
2024
38
0.450
Why?
Esophageal Neoplasms
1
2014
115
0.450
Why?
Catheterization, Central Venous
1
2013
12
0.450
Why?
Venous Thrombosis
1
2013
21
0.440
Why?
Barrett Esophagus
1
2014
114
0.440
Why?
Anemia
2
2024
32
0.440
Why?
Hepatitis C, Chronic
3
2021
64
0.440
Why?
Protease Inhibitors
1
2012
5
0.420
Why?
Transsexualism
3
2023
10
0.420
Why?
Longitudinal Studies
5
2021
710
0.410
Why?
Pregnancy Complications, Infectious
3
2021
136
0.400
Why?
Pandemics
4
2023
287
0.400
Why?
Disease Progression
6
2023
264
0.400
Why?
Stroke
1
2014
311
0.390
Why?
Sex Factors
6
2024
643
0.390
Why?
Nelfinavir
1
2011
4
0.380
Why?
Proton Pump Inhibitors
1
2011
24
0.370
Why?
Acne Vulgaris
2
2021
8
0.360
Why?
HIV Seronegativity
4
2007
9
0.360
Why?
Aging
5
2022
161
0.360
Why?
Liver Neoplasms
4
2021
40
0.350
Why?
Sexual Behavior
4
2017
124
0.350
Why?
European Continental Ancestry Group
5
2018
529
0.350
Why?
Gender Identity
7
2024
36
0.340
Why?
Gemfibrozil
1
2009
5
0.330
Why?
Hypolipidemic Agents
1
2009
40
0.320
Why?
Erectile Dysfunction
2
2019
24
0.320
Why?
Models, Theoretical
2
2019
70
0.310
Why?
Hispanic Americans
4
2021
404
0.310
Why?
Patient Protection and Affordable Care Act
3
2020
42
0.310
Why?
Tenofovir
3
2023
18
0.310
Why?
CD4-Positive T-Lymphocytes
3
2017
13
0.310
Why?
Epidemiologic Methods
4
2010
81
0.300
Why?
Logistic Models
8
2018
926
0.290
Why?
Drug Resistance, Viral
2
2017
12
0.280
Why?
Military Personnel
2
2006
12
0.280
Why?
Regression Analysis
6
2015
297
0.280
Why?
Neoplasm Invasiveness
3
2018
78
0.280
Why?
Prescriptions
2
2024
27
0.280
Why?
Drug Therapy, Combination
5
2021
114
0.280
Why?
Breast Neoplasms
3
2021
949
0.270
Why?
Lymphocyte Activation
2
2017
7
0.270
Why?
Human papillomavirus 16
1
2006
7
0.270
Why?
Insurance Coverage
3
2024
106
0.270
Why?
Antibodies, Viral
1
2006
65
0.260
Why?
Sexual Partners
3
2020
37
0.260
Why?
Time Factors
10
2017
1086
0.250
Why?
Clinical Trials as Topic
2
2020
130
0.250
Why?
Immune Tolerance
3
2017
6
0.240
Why?
Self-Injurious Behavior
2
2023
44
0.240
Why?
Body Mass Index
4
2018
958
0.240
Why?
Erythrocyte Indices
1
2024
2
0.240
Why?
Condoms
2
2020
33
0.240
Why?
Insurance, Life
1
2024
1
0.240
Why?
Insurance, Disability
1
2024
1
0.240
Why?
Administration, Intravenous
1
2024
6
0.240
Why?
Kidney Failure, Chronic
2
2017
147
0.240
Why?
Respiratory Tract Neoplasms
1
2004
2
0.240
Why?
Administration, Oral
1
2024
85
0.230
Why?
Demography
4
2020
101
0.230
Why?
HIV Integrase Inhibitors
2
2022
3
0.230
Why?
Glomerular Filtration Rate
5
2023
153
0.230
Why?
Carcinoma, Hepatocellular
2
2021
26
0.230
Why?
Severity of Illness Index
3
2021
454
0.220
Why?
Health Status Disparities
2
2019
146
0.220
Why?
Vaccination
2
2020
635
0.220
Why?
Lymphoma
2
2017
6
0.220
Why?
Survival Analysis
5
2016
215
0.220
Why?
Testosterone
2
2021
22
0.220
Why?
Cognition
1
2024
81
0.220
Why?
Laryngeal Neoplasms
1
2003
2
0.220
Why?
AIDS Serodiagnosis
1
2003
10
0.220
Why?
Infectious Disease Transmission, Vertical
1
2003
22
0.210
Why?
Raltegravir Potassium
2
2022
9
0.210
Why?
RNA
1
2022
12
0.210
Why?
Multivariate Analysis
7
2017
568
0.210
Why?
Depressive Disorder
4
2021
222
0.210
Why?
Genital Diseases, Female
1
2002
9
0.210
Why?
Gastrostomy
1
2022
3
0.210
Why?
Hormones
1
2022
14
0.210
Why?
Gonorrhea
1
2022
18
0.210
Why?
Medicare
3
2019
202
0.210
Why?
Chlamydia Infections
1
2022
25
0.210
Why?
Patient Readmission
1
2024
163
0.200
Why?
Self Report
1
2024
251
0.200
Why?
Surveys and Questionnaires
5
2024
1309
0.200
Why?
Sexually Transmitted Diseases
1
2022
54
0.200
Why?
Neoplasm Grading
2
2019
48
0.200
Why?
Infant, Newborn
7
2024
844
0.200
Why?
Chronic Disease
5
2020
428
0.200
Why?
Neoplasm Recurrence, Local
1
2004
244
0.200
Why?
Immunosuppression
2
2020
7
0.200
Why?
Odds Ratio
5
2017
671
0.190
Why?
Genetic Variation
2
2019
77
0.190
Why?
Research Design
3
2020
374
0.190
Why?
Bayes Theorem
4
2022
70
0.190
Why?
Biopsy
4
2017
74
0.190
Why?
Homeless Persons
1
2021
26
0.190
Why?
Housing
1
2021
39
0.190
Why?
Social Stigma
1
2021
18
0.190
Why?
Diabetes Mellitus
2
2024
487
0.190
Why?
Europe
4
2024
42
0.180
Why?
District of Columbia
1
2020
17
0.180
Why?
Drug Resistance, Multiple, Viral
2
2011
6
0.180
Why?
Reference Values
3
2018
91
0.180
Why?
Weight Gain
2
2020
173
0.180
Why?
Sex Distribution
3
2016
190
0.180
Why?
Child
12
2021
2474
0.180
Why?
Cooperative Behavior
3
2016
91
0.180
Why?
Validation Studies as Topic
1
2020
11
0.180
Why?
Benchmarking
1
2020
46
0.180
Why?
Pregnant Women
1
2021
45
0.180
Why?
Computer User Training
1
2000
2
0.180
Why?
Computer Literacy
1
2000
2
0.180
Why?
Heterocyclic Compounds, 3-Ring
1
2020
2
0.180
Why?
Alcohol-Related Disorders
1
2021
55
0.170
Why?
Kaplan-Meier Estimate
3
2015
129
0.170
Why?
Students, Medical
1
2000
18
0.170
Why?
Viremia
3
2020
9
0.170
Why?
Delivery of Health Care
4
2022
415
0.170
Why?
Practice Patterns, Physicians'
1
2023
330
0.170
Why?
Kidney Transplantation
2
2017
29
0.170
Why?
SEER Program
3
2017
91
0.170
Why?
Sexually Transmitted Diseases, Bacterial
1
2019
3
0.170
Why?
Biomarkers
3
2017
301
0.170
Why?
Diplopia
1
1999
1
0.170
Why?
Sensory Deprivation
1
1999
1
0.170
Why?
Vision, Binocular
1
1999
1
0.170
Why?
Macula Lutea
1
1999
2
0.170
Why?
Sleep Initiation and Maintenance Disorders
1
2020
39
0.170
Why?
Disease Transmission, Infectious
1
2019
13
0.170
Why?
Virus Replication
2
2011
12
0.170
Why?
Predictive Value of Tests
6
2017
351
0.170
Why?
Retinal Diseases
1
1999
16
0.170
Why?
Suicide, Attempted
1
2020
96
0.170
Why?
Coronavirus Infections
1
2020
49
0.160
Why?
Sigmoidoscopy
1
2019
65
0.160
Why?
Pneumonia, Viral
1
2020
56
0.160
Why?
Reproducibility of Results
1
2019
381
0.160
Why?
Cost-Benefit Analysis
1
2019
250
0.160
Why?
Chronic Pain
1
2020
127
0.150
Why?
Medical Records
1
2018
100
0.150
Why?
Adenoma
1
2019
93
0.150
Why?
Sex Reassignment Surgery
1
2017
2
0.150
Why?
Referral and Consultation
1
2019
167
0.150
Why?
United States Dept. of Health and Human Services
2
2014
7
0.150
Why?
Product Surveillance, Postmarketing
1
2018
95
0.150
Why?
Behavior Therapy
1
2019
146
0.150
Why?
Cell Cycle Proteins
2
2015
6
0.150
Why?
Apoptosis
2
2015
10
0.150
Why?
B-Lymphocytes
1
2017
4
0.150
Why?
Recurrence
3
2012
186
0.150
Why?
Transcriptome
1
2017
22
0.150
Why?
Gene Expression Profiling
1
2017
34
0.150
Why?
Diabetes Mellitus, Type 2
2
2017
748
0.150
Why?
Living Donors
1
2017
3
0.150
Why?
Prostatectomy
1
2017
75
0.150
Why?
Graft Rejection
1
2017
5
0.140
Why?
Genomics
1
2017
55
0.140
Why?
African Americans
4
2021
472
0.140
Why?
Colonoscopy
1
2019
251
0.140
Why?
Colonic Pouches
1
2016
1
0.140
Why?
Anal Canal
1
2016
7
0.140
Why?
Serogroup
1
2016
10
0.140
Why?
Medicaid
1
2018
186
0.140
Why?
Colitis, Ulcerative
1
2016
9
0.140
Why?
Streptococcus pneumoniae
1
2016
19
0.140
Why?
Patient Participation
2
2015
133
0.140
Why?
Neoplasm Staging
1
2018
325
0.140
Why?
Genetic Predisposition to Disease
1
2018
368
0.140
Why?
Vaccines, Conjugate
1
2016
59
0.140
Why?
Treatment Failure
3
2012
35
0.130
Why?
Kallikreins
1
2016
3
0.130
Why?
Internet
2
2013
231
0.130
Why?
Anxiety Disorders
3
2022
91
0.130
Why?
Risk Reduction Behavior
1
2016
108
0.130
Why?
Disease Management
1
2016
135
0.130
Why?
T-Lymphocyte Subsets
1
2015
4
0.130
Why?
Macrophages
1
2015
4
0.130
Why?
CD8-Positive T-Lymphocytes
1
2015
5
0.130
Why?
Health Status
1
2017
298
0.130
Why?
Guideline Adherence
1
2016
155
0.130
Why?
Child, Preschool
8
2018
1409
0.130
Why?
APACHE
1
2015
11
0.120
Why?
Hospitals, Teaching
1
2015
17
0.120
Why?
Apoptosis Regulatory Proteins
1
2015
4
0.120
Why?
National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division
1
2014
5
0.120
Why?
Head and Neck Neoplasms
1
2014
6
0.120
Why?
Pregnancy
4
2021
1494
0.120
Why?
Patient Acceptance of Health Care
2
2020
382
0.120
Why?
Infant
7
2022
1171
0.120
Why?
Vaginal Smears
4
2022
48
0.120
Why?
Healthcare Financing
1
2013
4
0.110
Why?
Denmark
2
2004
18
0.110
Why?
Government Programs
1
2013
11
0.110
Why?
Leg
1
2013
3
0.110
Why?
Ultrasonography
1
2013
35
0.110
Why?
Fibrin Fibrinogen Degradation Products
1
2013
7
0.110
Why?
Interleukin-6
1
2013
25
0.110
Why?
Appointments and Schedules
1
2013
26
0.110
Why?
Methicillin-Resistant Staphylococcus aureus
1
2013
6
0.110
Why?
Staphylococcal Infections
1
2013
14
0.110
Why?
Bile Ducts
2
1983
3
0.110
Why?
Lower Urinary Tract Symptoms
1
2013
13
0.110
Why?
C-Reactive Protein
1
2013
58
0.110
Why?
Office Visits
1
2013
80
0.110
Why?
Immunocompromised Host
1
2012
18
0.110
Why?
Epstein-Barr Virus Infections
1
2012
4
0.100
Why?
Melanoma
1
2013
35
0.100
Why?
Herpesvirus 3, Human
1
2012
44
0.100
Why?
Gene Expression Regulation, Neoplastic
1
2012
51
0.100
Why?
Cell Count
1
2012
10
0.100
Why?
Hepatitis, Viral, Human
2
1985
4
0.100
Why?
Patient Selection
1
2013
190
0.100
Why?
Tuberculosis
1
2011
20
0.100
Why?
Cytochrome P-450 CYP3A
1
2011
2
0.090
Why?
Aryl Hydrocarbon Hydroxylases
1
2011
6
0.090
Why?
Herpes Zoster
1
2012
82
0.090
Why?
Drug Interactions
1
2011
20
0.090
Why?
Cytochrome P-450 CYP2C19
1
2011
4
0.090
Why?
Drug Administration Schedule
5
2010
98
0.090
Why?
State Health Plans
1
2010
35
0.090
Why?
Analgesics
1
2010
27
0.090
Why?
Delayed Diagnosis
1
2010
19
0.090
Why?
DNA, Viral
3
2023
17
0.090
Why?
Fanconi Syndrome
1
2010
4
0.090
Why?
Organophosphonates
1
2010
7
0.090
Why?
Adenine
1
2010
8
0.090
Why?
Likelihood Functions
1
2010
44
0.090
Why?
Health Policy
2
2024
122
0.090
Why?
Appendicitis
1
2009
15
0.080
Why?
Quality Assurance, Health Care
1
2011
169
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2021
27
0.080
Why?
Immunologic Surveillance
1
2009
2
0.080
Why?
Urologic Diseases
1
2009
6
0.080
Why?
Prescription Drugs
1
2009
31
0.080
Why?
Hepatitis B virus
3
2023
20
0.080
Why?
Obesity
1
2015
837
0.080
Why?
Drug Overdose
1
2010
56
0.080
Why?
Oligopeptides
1
2008
6
0.080
Why?
Pyridines
1
2008
9
0.080
Why?
Ritonavir
1
2008
8
0.080
Why?
Genotype
2
2011
227
0.080
Why?
Triglycerides
1
2009
86
0.080
Why?
Mortality
1
2009
117
0.080
Why?
Cholesterol, LDL
1
2009
119
0.080
Why?
Anus Diseases
2
2005
2
0.080
Why?
Cholestasis, Intrahepatic
2
1990
2
0.080
Why?
Creatinine
2
2023
65
0.070
Why?
Serotonin Uptake Inhibitors
1
2008
71
0.070
Why?
Diabetes Mellitus, Type 1
1
2009
121
0.070
Why?
Substance Abuse, Intravenous
2
2021
33
0.070
Why?
Pharmacists
1
2007
48
0.070
Why?
Blood Glucose
1
2009
341
0.070
Why?
Liver
3
2019
32
0.070
Why?
Immunohistochemistry
2
2017
44
0.070
Why?
Muscle Contraction
2
1997
4
0.070
Why?
HIV Antibodies
1
2006
4
0.070
Why?
Risk-Taking
1
2007
109
0.070
Why?
Repressor Proteins
2
2019
13
0.070
Why?
Long-Term Care
3
2010
22
0.070
Why?
Papanicolaou Test
3
2016
37
0.060
Why?
Population Surveillance
2
2017
263
0.060
Why?
Drug Utilization
3
2010
127
0.060
Why?
Hospitalization
2
2021
797
0.060
Why?
Vulvar Neoplasms
1
2004
1
0.060
Why?
Hemoglobins
1
2024
39
0.060
Why?
Mutation
2
2017
128
0.060
Why?
Health Knowledge, Attitudes, Practice
1
2007
375
0.060
Why?
Carcinoma
1
2004
22
0.060
Why?
Kidney Function Tests
2
2017
22
0.060
Why?
Multimorbidity
1
2024
14
0.060
Why?
Proto-Oncogene Proteins c-bcl-6
2
2015
6
0.060
Why?
Survival Rate
2
2015
260
0.060
Why?
Multicenter Studies as Topic
1
2004
86
0.060
Why?
DNA-Binding Proteins
2
2015
29
0.060
Why?
Schools
1
2024
85
0.060
Why?
Delivery, Obstetric
1
2003
16
0.050
Why?
Military Medicine
1
2003
1
0.050
Why?
Eligibility Determination
1
2022
12
0.050
Why?
Kidney
1
2023
52
0.050
Why?
Rilpivirine
1
2022
1
0.050
Why?
Darunavir
1
2022
4
0.050
Why?
Causality
1
2022
40
0.050
Why?
Cause of Death
1
2023
181
0.050
Why?
Bias
1
2022
102
0.050
Why?
Quality of Life
2
2020
507
0.050
Why?
Social Isolation
1
2021
13
0.050
Why?
Vulnerable Populations
1
2021
39
0.050
Why?
Gastrointestinal Hemorrhage
2
2019
20
0.050
Why?
Income
1
2021
90
0.050
Why?
San Francisco
1
2020
64
0.050
Why?
Social Class
1
2021
120
0.050
Why?
Respiratory System
1
2020
3
0.040
Why?
MEDLINE
1
2000
1
0.040
Why?
Oxazines
1
2020
2
0.040
Why?
Piperazines
1
2020
9
0.040
Why?
New York
1
2000
20
0.040
Why?
Pyridones
1
2020
8
0.040
Why?
Educational Measurement
1
2000
18
0.040
Why?
Computer Communication Networks
1
2000
12
0.040
Why?
Health Services for the Aged
1
2020
14
0.040
Why?
Schools, Medical
1
2000
16
0.040
Why?
Poverty
1
2021
166
0.040
Why?
Betacoronavirus
1
2020
35
0.040
Why?
Esophageal and Gastric Varices
1
2019
4
0.040
Why?
Pregnancy Outcome
1
2021
154
0.040
Why?
Eyeglasses
1
1999
2
0.040
Why?
Cross-Cultural Comparison
1
2019
15
0.040
Why?
South Africa
1
2019
17
0.040
Why?
Liver Cirrhosis
1
2019
35
0.040
Why?
Florida
1
2019
8
0.040
Why?
Visual Acuity
1
1999
21
0.040
Why?
Data Collection
1
2020
256
0.040
Why?
Sustained Virologic Response
1
2019
17
0.040
Why?
Organ Specificity
1
2019
4
0.040
Why?
Gene Expression
1
2019
23
0.040
Why?
Patient Safety
1
2019
39
0.040
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2019
9
0.040
Why?
Machine Learning
1
2019
46
0.040
Why?
Patient Preference
1
2019
48
0.040
Why?
Melanocortins
1
2018
2
0.040
Why?
Washington
2
2010
374
0.040
Why?
Chromosomes, Human, Pair 6
1
2018
3
0.040
Why?
Promoter Regions, Genetic
1
2018
15
0.040
Why?
Alleles
1
2018
84
0.040
Why?
Leptin
1
2018
29
0.040
Why?
Georgia
1
2018
26
0.040
Why?
Attention Deficit and Disruptive Behavior Disorders
1
2018
10
0.040
Why?
Immunoglobulin Light Chains
1
2017
1
0.040
Why?
Neoplasm Metastasis
1
2017
31
0.040
Why?
Schizophrenia
1
2018
77
0.040
Why?
Immunoglobulin G
1
2017
29
0.040
Why?
Sequence Analysis, DNA
1
2017
30
0.040
Why?
Graft Survival
1
2017
3
0.040
Why?
Nephrectomy
1
2017
6
0.040
Why?
Gene Expression Regulation
1
2017
23
0.040
Why?
ROC Curve
1
2017
77
0.040
Why?
Adenosine Triphosphate
1
1997
1
0.040
Why?
Muscle, Smooth, Vascular
1
1997
2
0.040
Why?
Serotonin
1
1997
6
0.040
Why?
Confounding Factors (Epidemiology)
2
2009
86
0.040
Why?
Health Services Needs and Demand
1
2017
93
0.040
Why?
History, 21st Century
1
2017
24
0.040
Why?
Renal Insufficiency
1
2016
13
0.040
Why?
Patient Outcome Assessment
1
2017
28
0.030
Why?
Anastomosis, Surgical
1
2016
7
0.030
Why?
Diagnosis, Dual (Psychiatry)
1
2016
28
0.030
Why?
Qualitative Research
1
2017
254
0.030
Why?
Hepatitis, Chronic
1
2016
1
0.030
Why?
Developed Countries
1
2016
6
0.030
Why?
Cost Sharing
1
2016
30
0.030
Why?
Health Maintenance Organizations
2
2008
417
0.030
Why?
Sex Hormone-Binding Globulin
1
2016
22
0.030
Why?
Antigens, Differentiation, Myelomonocytic
1
2015
3
0.030
Why?
Antigens, CD
1
2015
5
0.030
Why?
Forkhead Transcription Factors
1
2015
6
0.030
Why?
Drug-Related Side Effects and Adverse Reactions
1
2016
107
0.030
Why?
Postoperative Complications
1
2016
102
0.030
Why?
Glomerular Mesangium
1
1995
1
0.030
Why?
Ileum
1
1975
1
0.030
Why?
Intestinal Neoplasms
1
1975
2
0.030
Why?
Arginine Vasopressin
1
1995
2
0.030
Why?
Diabetes Mellitus, Experimental
1
1995
3
0.030
Why?
Nutrition Surveys
1
2015
61
0.030
Why?
Calcium
1
1995
34
0.030
Why?
Glucose
1
1995
30
0.030
Why?
Datasets as Topic
1
2015
17
0.030
Why?
Autism Spectrum Disorder
1
2018
163
0.030
Why?
Proliferating Cell Nuclear Antigen
1
2015
3
0.030
Why?
Interferon Regulatory Factors
1
2015
3
0.030
Why?
Protein Kinase C beta
1
2015
3
0.030
Why?
Hyaluronan Receptors
1
2015
4
0.030
Why?
Proto-Oncogene Proteins c-myc
1
2015
5
0.030
Why?
Immunoglobulin M
1
2015
8
0.030
Why?
Sensitivity and Specificity
1
2016
304
0.030
Why?
Hepatitis A
3
1985
10
0.030
Why?
Crohn Disease
2
1985
14
0.030
Why?
Acute Disease
2
2005
142
0.030
Why?
Infant, Newborn, Diseases
2
1977
34
0.030
Why?
Poisson Distribution
1
2014
88
0.030
Why?
Antigens, Tumor-Associated, Carbohydrate
1
1993
1
0.030
Why?
Carcinoembryonic Antigen
1
1993
2
0.030
Why?
Dose-Response Relationship, Drug
2
2009
129
0.030
Why?
Chi-Square Distribution
1
2013
154
0.030
Why?
Hematologic Neoplasms
1
2012
7
0.030
Why?
Positive Regulatory Domain I-Binding Factor 1
1
2012
3
0.030
Why?
Ki-1 Antigen
1
2012
3
0.030
Why?
B7-1 Antigen
1
2012
3
0.030
Why?
LIM Domain Proteins
1
2012
3
0.030
Why?
In Situ Hybridization
1
2012
6
0.030
Why?
Adaptor Proteins, Signal Transducing
1
2012
15
0.030
Why?
Herpesvirus 4, Human
1
2012
6
0.030
Why?
NF-kappa B
1
2012
11
0.030
Why?
Proto-Oncogene Proteins
1
2012
32
0.030
Why?
Hepatovirus
2
1985
2
0.030
Why?
Hepatitis B Antigens
2
1985
2
0.030
Why?
Randomized Controlled Trials as Topic
1
2013
322
0.020
Why?
Coproporphyrins
1
1990
1
0.020
Why?
Porphyrins
1
1990
1
0.020
Why?
Photosensitivity Disorders
1
1990
3
0.020
Why?
Infant Nutritional Physiological Phenomena
1
1970
6
0.020
Why?
Gastrointestinal Diseases
1
1970
27
0.020
Why?
Morphine
1
2009
8
0.020
Why?
Urinary Bladder Diseases
1
2009
5
0.020
Why?
Bisexuality
1
2009
12
0.020
Why?
Urination Disorders
1
2009
10
0.020
Why?
Atazanavir Sulfate
1
2008
5
0.020
Why?
Models, Statistical
1
2009
177
0.020
Why?
Kidney Diseases
1
2008
53
0.020
Why?
Hepatolenticular Degeneration
2
1970
3
0.020
Why?
Insulin
1
2009
205
0.020
Why?
Vasoconstriction
2
1997
3
0.020
Why?
Rats
2
1997
29
0.020
Why?
Hypoglycemic Agents
1
2009
268
0.020
Why?
Outcome Assessment (Health Care)
1
2007
228
0.020
Why?
Animals
2
1997
259
0.020
Why?
Viral Hepatitis Vaccines
1
1985
1
0.020
Why?
Fetal Diseases
1
1985
8
0.020
Why?
Hepatitis B Antibodies
1
1985
6
0.020
Why?
Immunization, Passive
1
1985
3
0.020
Why?
Growth Disorders
1
1985
1
0.020
Why?
Polymerase Chain Reaction
1
2005
49
0.020
Why?
Body Height
1
1985
62
0.020
Why?
Fistula
1
1984
1
0.010
Why?
Rectal Fistula
1
1984
1
0.010
Why?
Abscess
1
1984
6
0.010
Why?
Probability
1
2004
79
0.010
Why?
Cholestasis, Extrahepatic
1
1983
1
0.010
Why?
Cholestasis
1
1983
1
0.010
Why?
Diagnostic Techniques, Surgical
1
1983
1
0.010
Why?
Diagnosis, Differential
1
1983
60
0.010
Why?
Cystic Fibrosis
2
1970
8
0.010
Why?
Cyclic AMP
1
1997
1
0.010
Why?
Serotonin Antagonists
1
1997
1
0.010
Why?
Serotonin Receptor Agonists
1
1997
1
0.010
Why?
8-Hydroxy-2-(di-n-propylamino)tetralin
1
1997
1
0.010
Why?
Theophylline
1
1997
3
0.010
Why?
Phosphodiesterase Inhibitors
1
1997
2
0.010
Why?
Rats, Wistar
1
1997
3
0.010
Why?
Pulmonary Artery
1
1997
3
0.010
Why?
Calcimycin
1
1995
1
0.010
Why?
Inositol Phosphates
1
1995
1
0.010
Why?
Endothelins
1
1995
1
0.010
Why?
In Vitro Techniques
1
1995
5
0.010
Why?
Muscle, Smooth
1
1995
3
0.010
Why?
Kinetics
1
1995
12
0.010
Why?
Rats, Sprague-Dawley
1
1995
8
0.010
Why?
Cells, Cultured
1
1995
12
0.010
Why?
Isomerism
1
1990
3
0.010
Why?
Syndrome
1
1990
28
0.010
Why?
Carbohydrate Metabolism, Inborn Errors
1
1970
1
0.010
Why?
Galactosemias
1
1970
1
0.010
Why?
Bile
1
1970
4
0.010
Why?
Tyrosine
1
1970
2
0.010
Why?
India
1
1970
13
0.010
Why?
Celiac Disease
1
1970
1
0.010
Why?
Esophageal Atresia
1
1970
1
0.010
Why?
Hyperbilirubinemia, Hereditary
1
1970
1
0.010
Why?
Intestinal Atresia
1
1970
1
0.010
Why?
Megacolon
1
1970
1
0.010
Why?
Protein-Losing Enteropathies
1
1970
1
0.010
Why?
Biliary Tract
1
1970
2
0.010
Why?
Duodenal Diseases
1
1970
3
0.010
Why?
Intestinal Obstruction
1
1970
2
0.010
Why?
Constipation
1
1970
4
0.010
Why?
Peptic Ulcer
1
1970
14
0.010
Why?
Intestinal Perforation
1
1970
8
0.010
Why?
Pancreatitis
1
1970
50
0.010
Why?
Body Weight
1
1970
219
0.010
Why?
Fissure in Ano
1
1984
1
0.000
Why?
Proctocolitis
1
1984
1
0.000
Why?
Puberty
1
1985
58
0.000
Why?
Concepts (630)
Explore
_
Co-Authors (36)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2025 Kaiser Permanente